Article
Ferring's C. difficile drug overcomes skepticism to secure FDA committee nod
Rating:
0.0
Views:
67
Likes:
1
Library:
1
Ferring Pharmaceuticals' biotherapeutic passed an FDA committee vote despite some skepticism from a handful of members, setting up the asset for potential approval to treat Clostridioides difficile | Ferring Pharmaceuticals' biotherapeutic passed an FDA committee vote despite some skepticism from a handful of members, setting up the asset for potential approval to treat C. difficile infection.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value